Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Many women with breast cancer who are treated with aromatase inhibitor medications develop
aches and pains during treatment, and some develop numbness and tingling in their hands and
feet. Some examples of aromatase inhibitor medications include anastrozole (Arimidex),
exemestane (Aromasin), and letrozole (Femara). Frequently, pain medications do not work very
well to relieve the pain. Duloxetine (Cymbalta) is a medication that was originally developed
to treat depression. It has also been found to relieve pain that occurs in people with
diabetes, fibromyalgia, arthritis, and other painful conditions. In this study we are testing
to see if duloxetine will help treat the pain that can occur in women treated with aromatase
inhibitors.
Phase:
N/A
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center